Auro Laboratories is a manufacturer of Active Pharmaceutical Ingredients (API's), Intermediates and Generic Formulations. Auro Laboratories was founded and incorporated in 1992 at Mumbai, with a manufacturing facility located at Tarapur, 120 Km from Mumbai. Since inception we have focused on providing quality pharmaceuticals while maintaining high manufacturing standards.

Our primary focus has been on Anti-Diabetic Drugs, which is estimated to be one of the fastest growing therapeutic segments. Currently, we manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, we also undertake Toll/Custom Manufacturing for API's and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum.
Auro laboratories has made its presence felt in international markets with a bulk of our production being exported to South East Asia, Middle East and several European Countries. Some of the countries we export to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom.
We believe in rigorous implementation our Quality Management Systems, which ensure the manufacturing of quality products with due environmental concerns. This has enabled us to successfully achieve ISO 9001:2000 and WHO - cGMP certifications. We have received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006 vide Certificate No.R0-CEP 2005-123- Rev 00.
Since inception, we have built a solid foundation & achieved steady growth over the years.
We believe this world help us propel to further heights in the future.

  • Auro Labs started its operations with Sodium Citrate and Potassium Iodide.
  • We then developed specific expertise in the antibacterial drug, Trimethoprim

  • We went for backward integration and started producing 3,4,5 Trimethoxy Benzaldehyde, the basic raw material for Trimethoprim
  • IPO of shares in 1996, currently listed on the Bombay Stock Exchange (BSE)

  • Achieved ISO 9001:2000 Certification

  • Achieved CERTIFICATE OF SUITABILITY(COS) from the European Directorate of Quality Medicine (EDQM)

  • Received DMF No 19910 from the FDA for Metformin Hydrochloride.